Orisild (Sildenafil)

Sildenafil selectively blocks phosphodiesterase type 5, an enzyme that degrades cyclic GMP. By preserving cyclic GMP, it promotes smooth‑muscle relaxation in the corpus cavernosum and pulmonary arteries, leading to increased blood flow that supports erection and lowers pulmonary arterial pressure.

The appropriate dose of Orisild is determined by a qualified prescriber based on the individual’s medical condition, response to therapy, and any concomitant medications. Patients should follow the dosing instructions provided by their healthcare professional.

Sildenafil is not recommended for use during pregnancy or while breastfeeding unless specifically prescribed by a healthcare provider. There is limited data on safety for the fetus or infant, so the risks and benefits must be carefully evaluated by a clinician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Orisild. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Orisild (sildenafil) shares the same class mechanism as other PDE5 inhibitors such as tadalafil and vardenafil. While all increase cyclic GMP to improve erectile function, they differ in duration of action, dosing frequency, and specific labeling for pulmonary arterial hypertension. Choice of agent depends on patient preference, clinical response, and physician assessment.

Orisild should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date printed on the label.

Orisild is taken orally, usually with a glass of water. It may be taken with or without food, but a high‑fat meal can delay its onset of action. Patients should follow the timing instructions given by their prescriber, typically about 30‑60 minutes before sexual activity for erectile dysfunction.

The most serious risks include priapism (a prolonged erection lasting more than four hours), sudden loss of vision or hearing, severe hypotension especially when combined with nitrates, and cardiovascular events such as myocardial infarction or stroke in susceptible individuals.

Orisild should not be used by individuals taking any form of nitrate medication, those with a known hypersensitivity to sildenafil or any component of the formulation, patients with severe uncontrolled hypertension, or anyone who has experienced a recent cardiovascular event without medical clearance.